Medical Properties Trust, Inc. (MPW)
NYSE: MPW · Real-Time Price · USD
4.790
+0.020 (0.42%)
At close: Feb 5, 2025, 4:00 PM
4.800
+0.010 (0.21%)
After-hours: Feb 5, 2025, 7:39 PM EST
Medical Properties Trust Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Medical Properties Trust stock have an average target of 4.92, with a low estimate of 4.00 and a high estimate of 6.50. The average target predicts an increase of 2.71% from the current stock price of 4.79.
Analyst Consensus: Hold
* Price targets were last updated on Dec 19, 2024.
Analyst Ratings
The average analyst rating for Medical Properties Trust stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 7 | 7 | 7 | 6 | 5 |
| Sell | 4 | 2 | 2 | 2 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 10 | 10 | 10 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $6 → $4 | Hold | Maintains | $6 → $4 | -16.49% | Dec 19, 2024 |
| Mizuho | Mizuho | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +4.38% | Dec 5, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $5 → $6 | Hold | Maintains | $5 → $6 | +25.26% | Sep 13, 2024 |
| Colliers Securities | Colliers Securities | Hold → Strong Buy Upgrades $6.5 | Hold → Strong Buy | Upgrades | $6.5 | +35.70% | Sep 13, 2024 |
| Exane BNP Paribas | Exane BNP Paribas | Buy → Hold Downgrades $6 → $4 | Buy → Hold | Downgrades | $6 → $4 | -16.49% | Jul 2, 2024 |
Financial Forecast
Revenue This Year
978.03M
Revenue Next Year
907.18M
from 978.03M
Decreased by -7.24%
EPS This Year
-3.20
from -0.93
EPS Next Year
-0.04
from -3.20
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.0B | 1.0B | 1.1B | |||
| Avg | 978.0M | 907.2M | 965.8M | |||
| Low | 919.4M | 799.1M | 847.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 3.6% | 20.6% | |||
| Avg | - | -7.2% | 6.5% | |||
| Low | - | -18.3% | -6.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.23 | 0.18 | 0.32 |
| Avg | -3.20 | -0.04 | -0.02 |
| Low | -3.21 | -0.47 | -0.70 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.